Lisdexamfetamine Dimesylate 00781-2478-01
- Manufacturer
- Sandoz Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 16, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA202836
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 40 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
00781-2478-01Selected100 CAPSULE in 1 BOTTLE (0781-2478-01)